Medidata Solutions (NASDAQ:MDSO) managed to stay afloat and traded higher with an addition of 0.3 point or 0.64% at $47.09. The money flow data is a negative $(-1.37) million with $6.57 million in upticks and $7.94 million in downticks. The intraday up/down ratio came in at 0.83. The shares have seen 3.97% change for the week in its share price.From the data available, it was found that a block transaction occurred during the course of trading. For it, the aggregated worth of the upticks was $0.93 million and the combined worth of the downticks was $2.38, Million, leading to the up/down ratio of 0.39. The block trade saw a net money flow of $(-1.45) million.
Currently the company Insiders own 6.7% of Medidata Solutions shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -8.08% . During last six month period, the net percent change held by insiders has seen a change of -7.93%. On the companys insider trading activities, The Securities and Exchange Commission has divulged that Sherif Tarek, director officer (Chairman & CEO) of Medidata Solutions, Inc., had unloaded 7,500 shares at an average price of $45.9 in a transaction dated on June 2, 2016. The total value of the transaction was worth $344,250.
Medidata Solutions (NASDAQ:MDSO) : On Monday heightened volatility was witnessed in Medidata Solutions (NASDAQ:MDSO) which led to swings in the share price. The stock opened for trading at $46.62 and hit $48 on the upside , eventually ending the session at $47.02, with a gain of 0.49% or 0.23 points. The heightened volatility saw the trading volume jump to 623,800 shares. The 52-week high of the share price is $61.308 and the company has a market cap of $2,694 million. The 52-week low of the share price is at $30.22 .
Many analysts have stated their opinion on the company shares. Equity analysts at the Brokerage firm Jefferies downgrades its rating on Medidata Solutions (NASDAQ:MDSO). The rating major has initiated the coverage with underperform rating on the shares. Earlier, the shares were rated a Hold by the brokerage firm. The rating by the firm was issued on April 26, 2016.
Medidata Solutions Inc. (Medidata) provides cloud-based solutions for life sciences. The Companys solutions are Medidata Rave, an electronic data capture (EDC) and clinical data management system (CDMS) solution; Medidata CTMS, a clinical trial management solution; Medidata Designer, a protocol design tool; Medidata Insights, which offer clinical business analytics and metrics; Medidata Balance, a randomization and trial supply management solution; Medidata Patient Cloud, an electronic patient-reported outcome (ePRO) application; Medidata Grants Manager, which develops and manages trial budgets; Medidata contract research organizations (CRO) Contractor, an analytics tool; Medidata SQM, a set of cloud-based site quality management dashboards; Medidata Coder, a medical coding and synonym management solution; Medidata Safety Gateway, which collects and transmits events and related data from the EDC system, and Medidata Targeted SDV, which implements risk-based monitoring strategies.